Gain Therapeutics is a preclinical stage biotech company developing next-generation brain-penetrant non-competitive small molecules for the treatment of devastating lysosomal storage diseases and CNS indications using the proprietary SEE-Tx® technology.
Cooperation possibilities
The company has several discovery programs that offer significant partnering opportunities. The proprietary SEE-Tx® technology can also provide partnering opportunities for the discovery of novel brain-penetrant small molecules against selected targets.
- https://www.gaintherapeutics.com
- +41 91 921 11 31
- info@gaintherapeutics.com
- Manolo Bellotto
